TABLE 4.

A list of differentially expressed miRNA associated with pathology from this study (FDR adjusted p-value less than 0.05).

miRNA	logFC	AveExpr	t	P.value	adj.P.val
IFG
hsa-miR-152-5p	−0.18	−1.07	−4.29	5.83E-05	3.14E-02
hsa-miR-296-3p	−0.12	1.95	−4.13	1.02E-04	3.14E-02
hsa-miR-212-5p	−0.22	5.41	−4.10	1.13E-04	3.14E-02
hsa-miR-210-3p	−0.15	3.83	−3.93	2.00E-04	3.57E-02
hsa-miR-4758-5p	0.23	−2.11	3.90	2.23E-04	3.57E-02
hsa-miR-1250-5p	−0.13	4.32	−3.86	2.57E-04	3.57E-02
hsa-miR-132-3p	−0.19	7.24	−3.73	3.92E-04	4.67E-02
Samples from all brain regions combined, but the statistical model additionally corrected for brain region
hsa-miR-212-5p	−0.19	5.65	−5.43	2.14E-07	1.79E-04
hsa-miR-5701	0.40	1.23	5.07	1.16E-06	3.42E-04
hsa-miR-132-5p	−0.16	7.40	−5.05	1.23E-06	3.42E-04
hsa-miR-132-3p	−0.13	7.72	−4.52	1.24E-05	2.59E-03
hsa-let-7e-3p	0.07	4.42	4.46	1.56E-05	2.60E-03
hsa-miR-187-3p	0.07	2.76	4.16	5.19E-05	7.17E-03
hsa-miR-383-5p	0.07	7.17	4.13	6.02E-05	7.17E-03
hsa-miR-302a-5p	0.15	0.66	4.01	9.59E-05	9.99E-03
hsa-miR-323b-3p	−0.12	7.65	−3.92	1.34E-04	1.24E-02
hsa-miR-222-5p	0.14	−0.80	3.80	2.08E-04	1.74E-02
hsa-miR-10395-3p	0.16	3.15	3.59	4.40E-04	3.34E-02
hsa-miR-30e-3p	0.04	9.70	3.50	6.04E-04	4.20E-02